Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Balances at Dec. 31, 2019	$ 51,812	$ 94,982,167	$ (86,935,593)	$ 177,385	$ 8,275,771
Balances (in Shares) at Dec. 31, 2019	518,125,454
Modification of warrants issued with debt		95,223			95,223
Stock-based compensation	$ 450	168,660			169,110
Stock-based compensation (in Shares)	4,500,000
Issuance of common stock to settle accounts payable	$ 11	8,259			8,270
Issuance of common stock to settle accounts payable (in Shares)	106,192
Net loss			(3,836,421)		(3,836,421)
Foreign currency translation				(116,264)	(116,264)
Balances at Mar. 31, 2020	$ 52,273	95,254,309	(90,772,014)	61,121	4,595,689
Balances (in Shares) at Mar. 31, 2020	522,731,646
Balances at Dec. 31, 2020	$ 58,927	102,594,341	(98,234,151)	160,642	4,579,759
Balances (in Shares) at Dec. 31, 2020	589,272,023
Stock-based compensation		626,579			626,579
Convertible note and accrued interest converted to common stock	$ 99	123,981			124,080
Convertible note and accrued interest converted to common stock (in Shares)	988,500
Cashless stock option exercises	$ 534	(534)
Cashless stock option exercises (in Shares)	5,343,599
Cashless warrant exercise	$ 788	(788)
Cashless warrant exercise (in Shares)	7,882,766
Net loss			(2,489,999)		(2,489,999)
Foreign currency translation				40,356	40,356
Balances at Mar. 31, 2021	$ 60,348	$ 103,343,579	$ (100,724,150)	$ 200,998	$ 2,880,775
Balances (in Shares) at Mar. 31, 2021	603,486,888